Sumitomo Mitsui DS Asset Management Company Ltd Boosts Holdings in Lam Research Corporation $LRCX

Sumitomo Mitsui DS Asset Management Company Ltd boosted its position in shares of Lam Research Corporation (NASDAQ:LRCX - Free Report) by 3.4% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 168,519 shares of the semiconductor company's stock after purchasing an additional 5,551 shares during the quarter. Sumitomo Mitsui DS Asset Management Company Ltd's holdings in Lam Research were worth $28,847,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. PMV Capital Advisers LLC bought a new position in Lam Research in the 4th quarter valued at approximately $25,000. Stance Capital LLC bought a new position in shares of Lam Research during the third quarter valued at $26,000. Triumph Capital Management purchased a new stake in shares of Lam Research during the third quarter valued at $27,000. Harbor Investment Advisory LLC lifted its holdings in shares of Lam Research by 73.9% during the 4th quarter. Harbor Investment Advisory LLC now owns 240 shares of the semiconductor company's stock valued at $41,000 after buying an additional 102 shares during the period. Finally, WealthCollab LLC boosted its stake in shares of Lam Research by 29.3% in the 4th quarter. WealthCollab LLC now owns 243 shares of the semiconductor company's stock worth $42,000 after buying an additional 55 shares during the last quarter. 84.61% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other news, Director Eric Brandt sold 35,000 shares of Lam Research stock in a transaction that occurred on Friday, February 6th. The stock was sold at an average price of $225.60, for a total value of $7,896,000.00. Following the completion of the transaction, the director owned 253,705 shares in the company, valued at approximately $57,235,848. The trade was a 12.12% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Douglas R. Bettinger sold 50,057 shares of the stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $224.03, for a total value of $11,214,269.71. Following the sale, the chief financial officer owned 1,081,705 shares in the company, valued at $242,334,371.15. The trade was a 4.42% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 155,066 shares of company stock valued at $35,849,242. Insiders own 0.31% of the company's stock.

Wall Street Analyst Weigh In

A number of research firms recently commented on LRCX. Wells Fargo & Company upped their price objective on Lam Research from $290.00 to $320.00 and gave the company an "overweight" rating in a research report on Thursday, April 23rd. Mizuho raised their target price on Lam Research from $295.00 to $330.00 and gave the stock an "outperform" rating in a research report on Thursday, April 23rd. Oppenheimer restated an "outperform" rating and set a $330.00 price target on shares of Lam Research in a research note on Thursday, April 23rd. BNP Paribas Exane increased their price objective on shares of Lam Research from $250.00 to $260.00 and gave the stock a "neutral" rating in a research note on Thursday, April 23rd. Finally, Zacks Research downgraded shares of Lam Research from a "strong-buy" rating to a "hold" rating in a report on Monday, April 6th. Twenty-six analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $285.94.

Lam Research Trading Up 6.7%

LRCX stock opened at $275.80 on Wednesday. The firm has a fifty day moving average price of $236.99 and a 200 day moving average price of $202.86. Lam Research Corporation has a fifty-two week low of $72.59 and a fifty-two week high of $280.00. The firm has a market cap of $344.91 billion, a PE ratio of 52.04, a price-to-earnings-growth ratio of 2.14 and a beta of 1.81. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.77 and a current ratio of 2.54.

Lam Research (NASDAQ:LRCX - Get Free Report) last released its quarterly earnings results on Wednesday, April 22nd. The semiconductor company reported $1.47 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.36 by $0.11. The company had revenue of $5.84 billion for the quarter, compared to the consensus estimate of $5.70 billion. Lam Research had a net margin of 30.94% and a return on equity of 66.21%. Lam Research's revenue was up 23.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.04 earnings per share. Lam Research has set its Q4 2026 guidance at 1.500-1.800 EPS. Sell-side analysts anticipate that Lam Research Corporation will post 5.68 earnings per share for the current fiscal year.

Key Stories Impacting Lam Research

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Earnings beat + bullish near‑term guide — Lam reported a March‑quarter revenue and EPS beat and gave an upbeat June‑quarter outlook, which the market interpreted as accelerating wafer‑fab demand and margin expansion. Lam Research jumps 7% as earnings beat and June-quarter outlook signals accelerating wafer-fab demand
• Positive Sentiment: TAM and secular demand lift the investment case — Analysts and commentators raised WFE and hyperscaler‑capex forecasts (Lam’s environment looks larger), reinforcing growth expectations and the claim that AI-driven device complexity benefits Lam’s etch/deposition exposure. Lam Research: $140B WFE, $725B In Hyperscaler Capex, And Still Raising -- BUY
• Positive Sentiment: Analyst target upgrades and bullish notes — Multiple firms have raised price targets and reiterated Outperform/Buy calls after the quarter, supporting momentum and upside thesis. Lam Research (LRCX) Surges to Record Highs: Analyzing the 252% Rally
• Positive Sentiment: Technical breakout / IBD recognition — The stock cleared an IBD buy point after the strong report, drawing momentum and retail/institutional interest. Lam Research, IBD Stock Of The Day, Clears Buy Point On Chip-Gear Investments
• Neutral Sentiment: Insider sale disclosed — An SVP sold ~18k shares under a pre‑arranged Rule 10b5‑1 plan; routine disclosure but worth noting for timing/context. Insider Selling: Lam Research NASDAQ: LRCX SVP Sells 18,170 Shares of Stock
• Neutral Sentiment: Valuation and “froth” commentary — Some analysis flags stretched multiples and consolidation risk after the run; elevated P/E requires investors to weigh growth vs. premium valuation. Lam Research Is Approaching Frothy Levels
• Negative Sentiment: Insider and institutional selling activity — Reports show multiple executive sales and notable institutional repositioning in recent quarters; while some are pre‑planned or rebalancing, sustained selling can temper sentiment if it continues. Lam Research jumps 7% as earnings beat and June-quarter outlook signals accelerating wafer-fab demand

Lam Research Profile

Lam Research Corporation NASDAQ: LRCX is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam's product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.